In this Part 3 and last in the series of Today's Veterinary Practice articles, "Canine Pituitary Dependent Hyperadrenocorticism," current and investigative therapies are discussed. These include adrenal-directed therapy, pituitary-directed therapy and glucocorticoid receptor blockade.
(Please refer to the blog post on this webpage for Part 1 of this series, “Comparative Epidemiology & Etiology in Dogs & Humans" (November/December 2015) and Part 2 "Diagnostic Approach" (January/February 2016) or access them at tvpjournal.com.)
Today’s Veterinary Practice | Canine Pituitary Dependent Hyperadrenocorticism Series Part 3: Current & Investigative Options for Therapy
March 22, 2016
Veterinary Debt: Does it Make Financial Sense to Become a Veterinarian?
November 24, 2013
2016 AAFP Guidelines for the Management of Feline Hyperthyroidism